
Syndicate Bio
Genomics company bringing precision-medicine testing and datasets to patients and providers across Africa.

Genomics company bringing precision-medicine testing and datasets to patients and providers across Africa.
syndicate.bioCrawled Oct 21, 2026
Empowering Inclusive Advancements in Global Genomics Science
Syndicate Bio, a global genomics and precision-medicine company, aims to create inclusive health datasets from diverse populations, starting in Africa, and convert them into insights for patients, healthcare providers, and life-science partners.
Syndicate Bio’s **Direct** platform introduces AI-driven genomic and multi-omics testing in Lagos, Nigeria, via a new sequencing lab. The launch includes panels for hereditary cancer, somatic oncology, non-invasive prenatal testing (NIPT), pharmacogenomics, and health & wellness diagnostics. The service aims to bring advanced precision medicine tools locally for the first time.
Oct 2025 · Yahoo FinanceNews article
Africa’s leading health innovation company, **Syndicate Bio**, introduces the **Direct by Syndicate Bio** platform to enable locally derived genomic data for preventing, diagnosing, and treating cancers, cardiovascular diseases, and sickle cell disease. The platform aims to expand access to precision medicine across the continent by leveraging African-specific genetic insights. Syndicate Bio positions itself as a key player in advancing healthcare innovation through advanced genetic testing solutions.
Oct 2025 · HealthwiseNews article
Syndicate Bio opens an AI-driven genomics lab in Lagos, Nigeria, providing genetic testing and precision medicine services. The platform targets Africa’s distinct genetic diversity to deliver localized healthcare solutions. This marks the company’s expansion into African markets with advanced biotech tools.
Oct 2025 · tech-ishNews article
Syndicate Bio introduces **Direct**, a genetic testing and precision medicine platform targeting patients and healthcare providers across Africa. The service aims to provide actionable genetic insights to improve medical outcomes in the region. Syndicate Bio positions itself as a pioneer in leveraging DNA data to drive personalized healthcare solutions.
Oct 2025 · TechCabalNews article